Huile Gao Selected Research

Cell-Penetrating Peptides

5/2016	Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
1/2016	Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.
1/2016	Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
11/2015	A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
1/2015	Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
10/2014	Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
8/2014	Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
7/2014	Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
2/2014	A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huile Gao Research Topics

Disease

97	Neoplasms (Cancer) 11/2022 - 12/2010
29	Glioma (Gliomas) 11/2019 - 12/2010
16	Breast Neoplasms (Breast Cancer) 12/2021 - 09/2013
12	Neoplasm Metastasis (Metastasis) 11/2021 - 12/2014
8	Brain Neoplasms (Brain Tumor) 01/2021 - 08/2015
7	Glioblastoma (Glioblastoma Multiforme) 06/2017 - 10/2011
5	Hypoxia (Hypoxemia) 03/2022 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 12/2021
3	Melanoma (Melanoma, Malignant) 05/2016 - 12/2014
2	Inflammation (Inflammations) 06/2022 - 12/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2015
2	Carcinoma (Carcinomatosis) 10/2021 - 12/2014
2	Triple Negative Breast Neoplasms 01/2017 - 12/2015
2	Necrosis 05/2016 - 02/2015
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Lung Diseases (Lung Disease) 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Autism Spectrum Disorder 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022

Drug/Important Bio-Agent (IBA)

42	Pharmaceutical PreparationsIBA 11/2022 - 06/2011
32	Peptides (Polypeptides)IBA 01/2021 - 07/2012
22	LigandsIBA 01/2021 - 10/2011
20	Liposomes (Liposome)IBA 07/2018 - 02/2014
15	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 12/2010
14	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 01/2014
10	IntegrinsIBA 07/2018 - 07/2014
9	EnzymesIBA 01/2022 - 11/2016
9	Cell-Penetrating PeptidesIBA 05/2016 - 02/2014
9	Docetaxel (Taxotere)FDA Link 01/2016 - 07/2012
8	GoldIBA 01/2022 - 01/2015
6	Transferrin (beta 2 Transferrin)IBA 05/2022 - 06/2011
6	CollagenIBA 01/2018 - 05/2015
6	Interleukin-13IBA 05/2014 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2014
5	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2021 - 01/2018
5	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 02/2015
5	Angiopep-2IBA 12/2015 - 08/2014
4	AcidsIBA 01/2022 - 01/2015
4	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2014
4	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 05/2015
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2015 - 10/2014
4	Lapatinib (GW572016)FDA Link 01/2014 - 11/2012
3	Biological ProductsIBA 03/2022 - 09/2015
3	Photosensitizing Agents (Photosensitizers)IBA 03/2022 - 01/2022
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022 - 10/2019
3	Antineoplastic Agents (Antineoplastics)IBA 03/2022 - 12/2010
3	CytokinesIBA 01/2022 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2020
3	Therapeutic UsesIBA 10/2020 - 01/2017
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2016 - 02/2014
3	GelatinIBA 12/2015 - 06/2015
3	CarbonIBA 11/2015 - 05/2014
3	AGRO 100IBA 06/2014 - 07/2012
2	BilirubinIBA 03/2022 - 01/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2021 - 01/2016
2	Oxygen (Dioxygen)IBA 09/2021 - 05/2015
2	NanovaccinesIBA 01/2021 - 11/2020
2	AntigensIBA 01/2021 - 01/2020
2	MicellesIBA 10/2020 - 04/2016
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2019 - 01/2016
2	asparaginylendopeptidase (legumain)IBA 11/2019 - 11/2016
2	cediranib (AZD2171)IBA 01/2019 - 10/2017
2	aspartic acid glycine arginineIBA 07/2018 - 03/2015
2	Evans Blue (Blue, Evans)FDA Link 01/2018 - 10/2017
2	LipidsIBA 01/2017 - 03/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2016 - 12/2014
2	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 12/2014
2	Lysine (L-Lysine)FDA Link 12/2015 - 01/2014
2	Arginine (L-Arginine)FDA Link 12/2015 - 01/2014
2	arginyl-glycyl-aspartic acidIBA 12/2015 - 01/2014
2	Lipid NanoparticlesIBA 12/2015 - 01/2014
2	Glutamic Acid (Glutamate)FDA Link 11/2015 - 01/2014
2	Matrix Metalloproteinases (MMPs)IBA 08/2015 - 06/2015
2	HydrazonesIBA 06/2015 - 01/2015
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2015 - 01/2014
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2015 - 10/2014
2	Cysteine (L-Cysteine)FDA Link 07/2014 - 01/2014
2	CholesterolIBA 05/2014 - 02/2014
2	Lipoproteins (Lipoprotein)IBA 09/2013 - 11/2012
1	Polystyrenes (Polystyrene)IBA 05/2022
1	morpholineIBA 03/2022
1	Lactate Dehydrogenase 5IBA 03/2022
1	Diclofenac (SR 38)FDA LinkGeneric 03/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	lipoxin A4IBA 01/2022
1	Explosive Agents (Explosives)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022

Therapy/Procedure

43	Therapeutics 11/2022 - 07/2012
19	Drug Therapy (Chemotherapy) 10/2021 - 12/2010
9	Immunotherapy 01/2022 - 01/2017
7	Lasers (Laser) 03/2022 - 01/2018
6	Photochemotherapy (Photodynamic Therapy) 03/2022 - 10/2020
5	Precision Medicine 12/2020 - 12/2013
3	Photothermal Therapy 11/2020 - 04/2013
2	Nanospheres 12/2015 - 05/2014
1	Chemoradiotherapy 01/2022